| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |